ImmunoGen, Inc.

ImmunoGen, Inc. is focused on the development of antibody-based anticancer therapeutics. The Company's Tumor-Activated Prodrug (TAP) technology uses antibodies to deliver a potent cytotoxic agent specifically to cancer cells. The antibody component enables a TAP compound to bind specifically to cancer cells that express a particular target antigen and the cytotoxic agent serves to kill the cancer cell. Its TAP technology is designed to enable the creation of anticancer products. The Company's TAP technology can be used with antibodies that have anticancer activity of their own to create compounds ...


There are no scholarships at this time


There are no events at this time

Company Data on ImmunoGen, Inc.
provided by Owler


ImmunoGen, Inc. is hiring for these positions

Show me: All available jobs